Technetium tc-99m sodium pertechnetate - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for technetium tc-99m sodium pertechnetate and what is the scope of patent protection?

Technetium tc-99m sodium pertechnetate is the generic ingredient in six branded drugs marketed by Ge Healthcare, Mallinckrodt, Pharmalucence, Bracco, Lantheus Medcl, Curium, and Northstar Medical, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

Sponsor	Phase
Mayo Clinic	Phase 1
National Cancer Institute (NCI)	Phase 1

Sponsor

Phase

Mayo Clinic

Phase 1

National Cancer Institute (NCI)

Phase 1

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lantheus Medcl	TECHNELITE	technetium tc-99m sodium pertechnetate generator	SOLUTION;INTRAVENOUS	017771-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ge Healthcare	SODIUM PERTECHNETATE TC 99M	technetium tc-99m sodium pertechnetate	SOLUTION;INJECTION, ORAL	017471-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Lantheus Medcl	TECHNELITE	technetium tc-99m sodium pertechnetate generator	SOLUTION;INTRAVENOUS	017771-002	Feb 12, 2014		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Curium	ULTRA-TECHNEKOW FM	technetium tc-99m sodium pertechnetate generator	SOLUTION;INTRAVENOUS	017243-003	Feb 18, 2014		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Curium	ULTRA-TECHNEKOW FM	technetium tc-99m sodium pertechnetate generator	SOLUTION;INTRAVENOUS	017243-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bracco	MINITEC	technetium tc-99m sodium pertechnetate generator	SOLUTION;INJECTION, ORAL	017339-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	6
Applicants:	7
NDAs:	8
Raw Ingredient (Bulk) Api Vendors:	4
Clinical Trials:	1
Patent Applications:	104
Formulation / Manufacturing:	see details
DailyMed Link:	technetium tc-99m sodium pertechnetate at DailyMed